BiomX PHGE
NYSE PHGE
$1.67 +0.12 (+7.74%)
As of: Sep 9, 2026 · 3:59 PM EDT

BiomX (PHGE) Total Current Liabilities (2018 - 2026)

BiomX's (PHGE) quarterly Total Current Liabilities came in at $10.2 million in Q2 2026, up 62.57% year-over-year from $6.3 million in Q2 2025, and up 316.02% quarter-over-quarter from $2.4 million in Q1 2026.

Analysis

BiomX (PHGE) Total Current Liabilities (2018 - 2026) Analysis & Trends

BiomX has disclosed Total Current Liabilities across 9 years of filings, most recently posting $10.2 million for Q2 2026.

  • In Q2 2026, Total Current Liabilities rose 62.57% year-over-year to $10.2 million; the TTM figure through Jun 2026 stood at $10.2 million (up 62.57% YoY), while the FY2025 annual figure was $6.4 million, down 22.84% from the prior year.
  • Total Current Liabilities came in at $10.2 million for Q2 2026 at BiomX, up from $2.4 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $12.8 million in Q3 2023 to a low of $2.4 million in Q1 2026.
  • Average Total Current Liabilities over 5 years is $8.2 million, with a median of $7.9 million recorded in 2022.
  • Year-over-year, Total Current Liabilities soared 79.77% in 2023 and slumped 65.15% in 2026.
  • Over 5 years, Total Current Liabilities stood at $7.9 million in 2022, then surged by 40.77% to $11.2 million in 2023, then slipped by 26.03% to $8.3 million in 2024, then decreased by 22.84% to $6.4 million in 2025, then soared by 59.59% to $10.2 million in 2026.
  • Per Business Quant data, the three most recent Total Current Liabilities figures were $10.2 million in Q2 2026, $2.4 million in Q1 2026, and $6.4 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 25.50 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 11.02 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 3.94 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 5.53 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 1.58 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 2.53 Bn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 1.51 Bn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 3.92 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 438.74 Mn
10 BiomX 1.55 Mn 7.73 Mn 97,000.00 10.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.18 Mn
Mar 31, 2026 2.45 Mn
Dec 31, 2025 6.38 Mn
Sep 30, 2025 5.23 Mn
Jun 30, 2025 6.26 Mn
Mar 31, 2025 7.02 Mn
Dec 31, 2024 8.27 Mn
Sep 30, 2024 8.94 Mn
Jun 30, 2024 7.31 Mn
Dec 31, 2023 11.18 Mn
Sep 30, 2023 12.78 Mn
Jun 30, 2023 11.67 Mn
Mar 31, 2023 10.20 Mn
Dec 31, 2022 7.94 Mn
Sep 30, 2022 7.48 Mn
Jun 30, 2022 6.49 Mn
Mar 31, 2022 9.85 Mn
Dec 31, 2021 11.04 Mn
Sep 30, 2021 9.00 Mn
Jun 30, 2021 7.76 Mn